Format

Send to

Choose Destination
Am J Trop Med Hyg. 2009 Jul;81(1):52-4.

Relapsing cutaneous leishmaniasis in a patient with ankylosing spondylitis treated with infliximab.

Author information

1
Medizinische Poliklinik, Divison of Infectious Diseases, University of Munich, Munich, Germany. matthias.mueller@med.uni-muenchen.de

Abstract

A 31-year-old man with ankylosing spondylitis, receiving treatment with infliximab, presented with a large progressive cutaneous ulcer at the right knee. Biopsies showed Leishmania amastigotes, and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis showed Leishmania infantum as the causative agent. After treatment with miltefosine, the ulcer resolved completely, and infliximab was reinstituted because of progression of spondylitis. After 1 year, there was a recurrent ulcer at the same site being positive for Leishmania DNA by PCR. Local treatment with sodium stibogluconate resulted in complete regression. Cutaneous leishmaniasis should be added to the list of opportunistic infections associated with anti-tumor necrosis factor (TNF) treatment. Despite recurrences, antileish-manial treatment may be effective in cases without alternatives to anti-TNF therapy.

PMID:
19556566
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center